SE0200598D0 - Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences - Google Patents
Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequencesInfo
- Publication number
- SE0200598D0 SE0200598D0 SE0200598A SE0200598A SE0200598D0 SE 0200598 D0 SE0200598 D0 SE 0200598D0 SE 0200598 A SE0200598 A SE 0200598A SE 0200598 A SE0200598 A SE 0200598A SE 0200598 D0 SE0200598 D0 SE 0200598D0
- Authority
- SE
- Sweden
- Prior art keywords
- lactoferrin
- treatment
- human
- hypoxic
- states
- Prior art date
Links
- 206010058558 Hypoperfusion Diseases 0.000 title abstract 3
- 206010021143 Hypoxia Diseases 0.000 title abstract 3
- 230000001146 hypoxic effect Effects 0.000 title abstract 3
- 230000000302 ischemic effect Effects 0.000 title abstract 3
- 208000019553 vascular disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 abstract 4
- 108010038047 apolactoferrin Proteins 0.000 abstract 4
- 102000050459 human LTF Human genes 0.000 abstract 4
- 239000002207 metabolite Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200598A SE0200598D0 (sv) | 2002-02-27 | 2002-02-27 | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| US10/505,569 US20050222007A1 (en) | 2002-02-27 | 2003-02-27 | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| AU2003210086A AU2003210086A1 (en) | 2002-02-27 | 2003-02-27 | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| EP03743090A EP1478387A1 (fr) | 2002-02-27 | 2003-02-27 | Composition pharmaceutique et methode de traitement ou de prevention d'une maladie vasculaire ou d'etats d'hypoperfusion tissulaire entrainant des consequences hypoxiques et/ou ischemiques |
| PCT/SE2003/000329 WO2003072129A1 (fr) | 2002-02-27 | 2003-02-27 | Composition pharmaceutique et methode de traitement ou de prevention d'une maladie vasculaire ou d'etats d'hypoperfusion tissulaire entrainant des consequences hypoxiques et/ou ischemiques |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200598A SE0200598D0 (sv) | 2002-02-27 | 2002-02-27 | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0200598D0 true SE0200598D0 (sv) | 2002-02-27 |
Family
ID=20287109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0200598A SE0200598D0 (sv) | 2002-02-27 | 2002-02-27 | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050222007A1 (fr) |
| EP (1) | EP1478387A1 (fr) |
| AU (1) | AU2003210086A1 (fr) |
| SE (1) | SE0200598D0 (fr) |
| WO (1) | WO2003072129A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090202574A1 (en) * | 2004-11-19 | 2009-08-13 | Jagat Rakesh Kanwar | Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| DE102009049702A1 (de) * | 2009-10-18 | 2011-04-21 | Vczs Venture Capital Zentralschweiz Ag | Verwendung von Lactoferrin und Lactoferrin enthaltende Zusammensetzungen |
| CN111879949B (zh) * | 2020-08-05 | 2021-11-09 | 中国科学院昆明动物研究所 | 检测或调控乳铁蛋白表达量的物质在制备预防和/或治疗心脑血管疾病药物或试剂盒的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07278011A (ja) * | 1994-04-01 | 1995-10-24 | Morinaga Milk Ind Co Ltd | 狭心症治療剤 |
| US5712247A (en) * | 1995-02-21 | 1998-01-27 | University Of North Carolina | Use of lactoferrin to modulate and/or neutralize heparin activity |
| JP3888707B2 (ja) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | 血管新生病治療剤 |
| JP2002515893A (ja) * | 1997-02-03 | 2002-05-28 | ファーミング インテレクチュアル プロパティ ビーブイ | ヒトラクトフェリンおよびその改変体の有用な特性 |
| FR2762850B1 (fr) * | 1997-05-02 | 2000-02-11 | Biocem | Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations |
| SE9804614A0 (en) * | 1998-07-06 | 2000-01-07 | A+ Science Invest Ab | New peptides and use thereof |
| GB9818938D0 (en) * | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
| US6426362B1 (en) * | 1999-10-08 | 2002-07-30 | Galileo Laboratories, Inc. | Formulations of tocopherols and methods of making and using them |
-
2002
- 2002-02-27 SE SE0200598A patent/SE0200598D0/xx unknown
-
2003
- 2003-02-27 AU AU2003210086A patent/AU2003210086A1/en not_active Abandoned
- 2003-02-27 WO PCT/SE2003/000329 patent/WO2003072129A1/fr not_active Application Discontinuation
- 2003-02-27 US US10/505,569 patent/US20050222007A1/en not_active Abandoned
- 2003-02-27 EP EP03743090A patent/EP1478387A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003072129A1 (fr) | 2003-09-04 |
| US20050222007A1 (en) | 2005-10-06 |
| EP1478387A1 (fr) | 2004-11-24 |
| AU2003210086A1 (en) | 2003-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| JP2002532432A5 (fr) | ||
| RU2001128504A (ru) | Композиции для стимулирования роста | |
| ATE432289T1 (de) | Glp-1 und behandlungsmethode für diabetes | |
| DE69933208D1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
| ATE279175T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verminderung des cellulite auftretens | |
| TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| CY1110078T1 (el) | Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων | |
| Gileva et al. | Hirudotherapy | |
| RU99120189A (ru) | Препараты для лечения метаболического синдрома, содержащие гормон роста человека в комбинации с ингибитором синтеза кортзола | |
| EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
| DE60115432D1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
| JP2002530353A5 (fr) | ||
| DE60313356D1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
| IL194500A (en) | A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above | |
| AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
| RU2005131578A (ru) | Аплидин для лечения множественной миеломы | |
| SE0200598D0 (sv) | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences | |
| CA2516458A1 (fr) | Utilisation de composes de kahalalide pour la fabrication d'un medicament pour le traitement de psoriasis | |
| ES2182840T3 (es) | Factor xiii para el tratamiento de heridas de la piel. | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| EA200600757A1 (ru) | Тетрапептид, регулирующий уровень глюкозы в крови при сахарном диабете | |
| JP2002529515A5 (fr) | ||
| JP2000178203A5 (fr) |